News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
280,130 Results
Type
Article (19212)
Company Profile (162)
Press Release (260756)
Multimedia
Podcasts (31)
Webinars (3)
Section
Business (77113)
Career Advice (318)
Deals (15479)
Drug Delivery (59)
Drug Development (38211)
Employer Resources (35)
FDA (7615)
Job Trends (7251)
News (139669)
Policy (13368)
Tag
Academia (1640)
Academic (1)
Accelerated approval (4)
Adcomms (11)
Allergies (44)
Alliances (22084)
ALS (52)
Alzheimer's disease (692)
Antibody-drug conjugate (ADC) (42)
Approvals (7683)
Artificial intelligence (138)
Autoimmune disease (10)
Automation (9)
Bankruptcy (120)
Best Places to Work (6813)
BIOSECURE Act (7)
Biosimilars (60)
Biotechnology (119)
Bladder cancer (42)
Brain cancer (14)
Breast cancer (148)
Cancer (1218)
Cardiovascular disease (112)
Career advice (280)
Career pathing (7)
CAR-T (80)
Cell therapy (229)
Cervical cancer (10)
Clinical research (31761)
Collaboration (493)
Compensation (210)
Complete response letters (8)
COVID-19 (1155)
CRISPR (33)
C-suite (149)
Cystic fibrosis (65)
Data (1373)
Decentralized trials (1)
Denatured (15)
Depression (20)
Diabetes (168)
Diagnostics (2706)
Digital health (9)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (75)
Drug pricing (63)
Drug shortages (17)
Duchenne muscular dystrophy (62)
Earnings (24587)
Editorial (13)
Employer branding (3)
Employer resources (33)
Events (41243)
Executive appointments (433)
FDA (8352)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (378)
Gene editing (79)
Generative AI (14)
Gene therapy (192)
GLP-1 (410)
Government (1731)
Grass and pollen (1)
Guidances (31)
Healthcare (9067)
Huntington's disease (11)
IgA nephropathy (18)
Immunology and inflammation (50)
Indications (21)
Infectious disease (1236)
Inflammatory bowel disease (101)
Inflation Reduction Act (4)
Influenza (32)
Intellectual property (46)
Interviews (35)
IPO (8187)
IRA (21)
Job creations (906)
Job search strategy (254)
Kidney cancer (7)
Labor market (8)
Layoffs (136)
Leadership (2)
Legal (2552)
Liver cancer (34)
Lung cancer (178)
Lymphoma (102)
Machine learning (3)
Management (10)
Manufacturing (157)
MASH (42)
Medical device (4146)
Medtech (4147)
Mergers & acquisitions (7704)
Metabolic disorders (419)
Multiple sclerosis (41)
NASH (13)
Neurodegenerative disease (40)
Neuropsychiatric disorders (10)
Neuroscience (987)
NextGen: Class of 2025 (2839)
Non-profit (1819)
Now hiring (8)
Obesity (228)
Opinion (74)
Ovarian cancer (43)
Pain (60)
Pancreatic cancer (41)
Parkinson's disease (76)
Partnered (13)
Patents (105)
Patient recruitment (53)
Peanut (24)
People (26733)
Pharmaceutical (34)
Pharmacy benefit managers (8)
Phase I (9054)
Phase II (13158)
Phase III (12012)
Pipeline (648)
Policy (69)
Postmarket research (1503)
Preclinical (3647)
Press Release (15)
Prostate cancer (57)
Psychedelics (10)
Radiopharmaceuticals (167)
Rare diseases (237)
Real estate (1960)
Recruiting (10)
Regulatory (10256)
Reports (16)
Research institute (1434)
Resumes & cover letters (31)
Rett syndrome (4)
RNA editing (3)
RSV (21)
Schizophrenia (43)
Series A (71)
Series B (49)
Service/supplier (1)
Sickle cell disease (40)
Special edition (6)
Spinal muscular atrophy (84)
Sponsored (11)
Startups (1705)
State (1)
Stomach cancer (6)
Supply chain (41)
Tariffs (25)
The Weekly (15)
Vaccines (309)
Venture capitalists (17)
Weight loss (134)
Women's health (15)
Worklife (1)
Date
Today (91)
Last 7 days (443)
Last 30 days (1343)
Last 365 days (17472)
2025 (5599)
2024 (18542)
2023 (20512)
2022 (25476)
2021 (27219)
2020 (25274)
2019 (20885)
2018 (15749)
2017 (14844)
2016 (13525)
2015 (15558)
2014 (10946)
2013 (8961)
2012 (9262)
2011 (9003)
2010 (7563)
Location
Africa (251)
Alabama (27)
Alaska (2)
Arizona (62)
Arkansas (4)
Asia (17782)
Australia (2468)
California (3165)
Canada (779)
China (292)
Colorado (101)
Connecticut (160)
Delaware (106)
Europe (37098)
Florida (486)
Georgia (85)
Idaho (21)
Illinois (275)
India (16)
Indiana (194)
Iowa (3)
Japan (128)
Kansas (52)
Kentucky (8)
Louisiana (4)
Maine (61)
Maryland (362)
Massachusetts (2568)
Michigan (93)
Minnesota (104)
Mississippi (2)
Missouri (47)
Montana (9)
Nebraska (7)
Nevada (33)
New Hampshire (19)
New Jersey (1124)
New Mexico (11)
New York (1013)
North Carolina (514)
North Dakota (5)
Northern California (1391)
Ohio (91)
Oklahoma (4)
Oregon (20)
Pennsylvania (701)
Puerto Rico (2)
Rhode Island (14)
South America (346)
South Carolina (8)
Southern California (1191)
Tennessee (43)
Texas (424)
United States (12197)
Utah (131)
Virginia (84)
Washington D.C. (34)
Washington State (311)
West Virginia (1)
Wisconsin (33)
280,130 Results for "minaris regenerative medicine llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Press Releases
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
March 6, 2025
·
4 min read
Business
Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault Quality Suite Applications
Veeva Systems (NYSE: VEEV) today announced that Minaris Regenerative Medicine selected Veeva Vault QualityDocs and Veeva Vault Training to advance its global quality operations.
May 24, 2023
·
4 min read
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Press Releases
Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy
April 10, 2025
·
2 min read
Cellusion and Minaris Regenerative Medicine, a member of Showa Denko Materials, Enter into Business Alliance for the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative Therapy
Cellusion Inc. and Minaris Regenerative Medicine, LLC announced Letter of Intent of the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative therapy in the United States.
October 12, 2022
·
4 min read
BioMidwest
Stimlabs(R) LLC Granted Issuance of Two New Patents Further Establishing the Company’s Intellectual Property Position for Advancements in Regenerative Medicine
Stimlabs LLC, a leader in regenerative medicine, continues to achieve advancements in the development and patenting of innovative, industry-leading technologies and products.
November 1, 2023
·
2 min read
Press Releases
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
March 6, 2025
·
5 min read
Press Releases
U-Factor Announces “Excellence Award” for ALS Research by Partner Hitonowa Medical Clinic at the 24th Congress of the Japanese Society for Regenerative Medicine
April 24, 2025
·
2 min read
Press Releases
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
April 16, 2025
·
4 min read
1 of 28,013
Next
